Abstract 4415: CDK4/6 inhibition with lerociclib (G1T38) delays acquired resistance to targeted therapies in preclinical models of non-small cell lung cancer
Keyword(s):
2019 ◽
Keyword(s):
2013 ◽
Vol 33
◽
pp. e272-e278
◽
Keyword(s):
2018 ◽
Keyword(s):
2014 ◽
Vol 92
(7)
◽
pp. 697-707
◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 32
(6)
◽
pp. 585-589
Keyword(s):
2016 ◽
Vol 11
(2)
◽
pp. 77-87
◽
Keyword(s):